Table 2.
IPV-DTaP | Hib | HBV | MMR | MenC | Pneumococcal | |
---|---|---|---|---|---|---|
Wallonia | (519) | |||||
Dose1 | 99.8 (99.4–100) | 99.2 (98.5–100) | 98.1 (96.9–99.3) | 94.4 (92.4–96.4) | 89.6 (87.0–92.2) | 97.1 (95.7–98.6) |
Dose2 | 99.2 (98.5–100) | 98.5 (97.4–99.5) | 97.2 (96.2–98.8) | 97.1 (95.7–98.6) | ||
Dose3 | 99.2 (98.5–100) | 98.5 (97.4–99.5) | 97.2 (96.2–98.8) | 89.2 (86.5–91.9) | ||
Dose4 | 90.4 (87.8–92.9) | 89.4 (86.8–92.1) | 89.2 (86.5–91.9) | |||
| ||||||
Brussels | (538) | |||||
Dose1 | 99.6 (99.1–100) | 97.3 (95.8–98.6) | 96.7 (95.1–98.2) | 94.1 (92.1–96.1) | 89.4 (87.0–92.2) | 97.0 (95.6–98.5) |
Dose2 | 99.3 (98.5–100) | 97.6 (96.6–98.9) | 96.8 (95.4–98.3) | 95.5 (93.8–97.3) | ||
Dose3 | 98.7 (97.7–99.7) | 96.7 (95.1–98.2) | 96.3 (94.7–97.9) | 90.1 (87.6–92.7) | ||
Dose4 | 91.1 (88.7–93.5) | 90.1 (87.6–92.7) | 89.6 (87.0–92.2) |